Literature DB >> 15006522

What is transforming growth factor-beta (TGF-beta)?

David Chin1, Glen M Boyle, Peter G Parsons, William B Coman.   

Abstract

The TGF-beta superfamily of proteins produces a wide range of frequently opposing effects in different cells and tissues in the body. However, its activation and mode of action are only partially understood because of its complexity in structure and functions and the variability in its downstream targets. Current work on these cytokines focuses on their receptors and the intercellular signalling pathways, comparing bioactivities between cell types and tracking their physiological and immunological effects in vivo. Future research will yield important therapeutic applications and the ability to manipulate these proteins in vivo.

Mesh:

Substances:

Year:  2004        PMID: 15006522     DOI: 10.1016/j.bjps.2003.12.012

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  24 in total

1.  Detection of Angiotensin II and AT1 Receptor Concentrations in Keloid and Hypertrophic Scar.

Authors:  Feizollah Niazi; Seyed Hassan Hooshyar; Keshvad Hedayatyanfard; Seyed Ali Ziai; Farideh Doroodgar; Sana Niazi; Behnam Habibi; Ali Asadirad
Journal:  J Clin Aesthet Dermatol       Date:  2018-10-01

Review 2.  Role of transforming growth factor Beta in corneal function, biology and pathology.

Authors:  A Tandon; J C K Tovey; A Sharma; R Gupta; R R Mohan
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

3.  Nerve growth factor modulates in vitro the expression and release of TGF-beta1 by amniotic membrane.

Authors:  Marco Coassin; Alessandro Lambiase; Alessandra Micera; Paola Tirassa; Luigi Aloe; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-13       Impact factor: 3.117

4.  Effects of transforming growth factor-beta in the development of inflammatory pseudotumour-like lesions in a murine model.

Authors:  Luciana Doria Guariniello; Mariangela Correa; Miriam Galvonas Jasiulionis; Joel Machado; José Antônio Silva; João Bosco Pesquero; Célia Regina Whitaker Carneiro
Journal:  Int J Exp Pathol       Date:  2006-06       Impact factor: 1.925

Review 5.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

6.  TGF-beta1 attenuates mediator release and de novo Kit expression by human skin mast cells through a Smad-dependent pathway.

Authors:  Wei Zhao; Gregorio Gomez; Shao-Hua Yu; John J Ryan; Lawrence B Schwartz
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  PAI-1 Regulates the Invasive Phenotype in Human Cutaneous Squamous Cell Carcinoma.

Authors:  Jennifer Freytag; Cynthia E Wilkins-Port; Craig E Higgins; J Andrew Carlson; Agnes Noel; Jean-Michel Foidart; Stephen P Higgins; Rohan Samarakoon; Paul J Higgins
Journal:  J Oncol       Date:  2010-03-01       Impact factor: 4.375

Review 8.  The influence of tissue microenvironment on stem cell-based cartilage repair.

Authors:  Chathuraka T Jayasuriya; Yupeng Chen; Wenguang Liu; Qian Chen
Journal:  Ann N Y Acad Sci       Date:  2016-07-27       Impact factor: 5.691

9.  Combined use of RGD-peptide modified PLGA and TGF-beta1 gene transfected MSCs to improve cell biobehaviors in vitro.

Authors:  Changwen Li; Qixin Zheng; Xiaodong Guo; Daping Quan; Jie Zhao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

10.  Transforming growth factor-beta regulates in vitro heart valve repair by activated valve interstitial cells.

Authors:  Amber C Liu; Avrum I Gotlieb
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.